{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:17:50Z","timestamp":1790252270516,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100022115","name":"Dutch Arthritis Association","doi-asserted-by":"publisher","award":["LLP14, 13-02-201, 15-03-403"],"award-info":[{"award-number":["LLP14, 13-02-201, 15-03-403"]}],"id":[{"id":"10.13039\/501100022115","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health~Holland TKI-LSH","award":["NSP18-1-405"],"award-info":[{"award-number":["NSP18-1-405"]}]},{"name":"Stichting the Weijerhorst"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03599-4","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:02:41Z","timestamp":1753873361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploration of bioactive variants of the BMP7-derived p[63\u201382] peptide for ameliorating the OA-associated chondrocyte phenotype"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7860-4419","authenticated-orcid":false,"given":"Jessica S. J.","family":"Steijns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8081-4466","authenticated-orcid":false,"given":"Tim J. M.","family":"Welting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Cremers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7071-1487","authenticated-orcid":false,"given":"Guus G. H. van den","family":"Akker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9370-5525","authenticated-orcid":false,"given":"Pieter J.","family":"Emans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lodewijk W. van","family":"Rhijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5316-9211","authenticated-orcid":false,"given":"Marjolein M. J.","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"3599_CR1","doi-asserted-by":"crossref","unstructured":"Anderson AS, Loeser RF. Why is osteoarthritis an age-related disease? Best Pract Res Clin Rheumatol. 2010;24(1):15\u201326.","DOI":"10.1016\/j.berh.2009.08.006"},{"key":"3599_CR2","doi-asserted-by":"crossref","unstructured":"Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol. 2006;20(1):3\u201325.","DOI":"10.1016\/j.berh.2005.09.007"},{"key":"3599_CR3","doi-asserted-by":"crossref","unstructured":"Clynes MA, Jameson KA, Edwards MH, Cooper C, Dennison EM. Impact of osteoarthritis on activities of daily living: does joint site matter? Aging Clin Exp Res. 2019;31:1049\u201356.","DOI":"10.1007\/s40520-019-01163-0"},{"key":"3599_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2474-11-86","volume":"11","author":"JA Zeni","year":"2010","unstructured":"Zeni JA, Axe MJ, Snyder-Mackler L. Clinical predictors of elective total joint replacement in persons with end-stage knee osteoarthritis. BMC Musculoskelet Disord. 2010;11:1\u20138.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"3599_CR5","doi-asserted-by":"publisher","first-page":"19663","DOI":"10.1038\/s41598-021-99096-0","volume":"11","author":"EG Ripmeester","year":"2021","unstructured":"Ripmeester EG, van den Caron MM, Steijns J, Surtel DA, Cremers A, et al. BMP7 reduces the fibrocartilage chondrocyte phenotype. Sci Rep. 2021;11(1):19663.","journal-title":"Sci Rep"},{"issue":"4","key":"3599_CR6","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.joca.2013.01.009","volume":"21","author":"M Caron","year":"2013","unstructured":"Caron M, Emans P, Cremers A, Surtel D, Coolsen M, Van Rhijn L, et al. Hypertrophic differentiation during chondrogenic differentiation of progenitor cells is stimulated by BMP-2 but suppressed by BMP-7. Osteoarthr Cartil. 2013;21(4):604\u201313.","journal-title":"Osteoarthr Cartil"},{"key":"3599_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2521","volume":"10","author":"M Hayashi","year":"2008","unstructured":"Hayashi M, Muneta T, Ju Y-J, Mochizuki T, Sekiya I. Weekly intra-articular injections of bone morphogenetic protein-7 inhibits osteoarthritis progression. Arthritis Res Therapy. 2008;10:1\u20139.","journal-title":"Arthritis Res Therapy"},{"key":"3599_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.omtm.2021.03.009","volume":"21","author":"MM Caron","year":"2021","unstructured":"Caron MM, van den Ripmeester EG, Wijnands NK, Steijns J, Surtel DA, et al. Discovery of bone morphogenetic protein 7-derived peptide sequences that attenuate the human Osteoarthritic chondrocyte phenotype. Mol Therapy-Methods Clin Dev. 2021;21:247\u201361.","journal-title":"Mol Therapy-Methods Clin Dev"},{"key":"3599_CR9","doi-asserted-by":"crossref","unstructured":"Ripmeester EG, Steijns JS, Wijnands KA, Stassen RH, Pitelka V, Peeters LC et al. The BMP7-Derived peptide p [63\u201382] reduces cartilage degeneration in the rat ACLT\u2013pMMx model for posttraumatic osteoarthritis. Cartilage. 2024:19476035241233659.","DOI":"10.1177\/19476035241233659"},{"issue":"5","key":"3599_CR10","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1136\/ard.2004.022434","volume":"64","author":"I Tchetverikov","year":"2005","unstructured":"Tchetverikov I, Lohmander L, Verzijl N, Huizinga T, TeKoppele J, Hanemaaijer R, et al. MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis. Ann Rheum Dis. 2005;64(5):694\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"17","key":"3599_CR11","doi-asserted-by":"publisher","first-page":"9208","DOI":"10.3390\/ijms22179208","volume":"22","author":"V Molnar","year":"2021","unstructured":"Molnar V, Mati\u0161i\u0107 V, Kodvanj I, Bjelica R, Jele\u010d \u017d, Hudetz D, et al. Cytokines and chemokines involved in osteoarthritis pathogenesis. Int J Mol Sci. 2021;22(17):9208.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3599_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","volume":"7","author":"L Wang","year":"2022","unstructured":"Wang L, Wang N, Zhang W, Cheng X, Yan Z, Shao G, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Therapy. 2022;7(1):48.","journal-title":"Signal Transduct Target Therapy"},{"issue":"10","key":"3599_CR13","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.joca.2012.06.016","volume":"20","author":"MM Caron","year":"2012","unstructured":"Caron MM, Emans PJ, Coolsen MM, Voss L, Surtel DA, Cremers A, et al. Redifferentiation of dedifferentiated human articular chondrocytes: comparison of 2D and 3D cultures. Osteoarthr Cartil. 2012;20(10):1170\u20138.","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"3599_CR14","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41598-020-80451-6","volume":"11","author":"M Neefjes","year":"2021","unstructured":"Neefjes M, Van Den Housmans B, Van Rhijn L, Van Der Welting T. Reporter gene comparison demonstrates interference of complex body fluids with secreted luciferase activity. Sci Rep. 2021;11(1):1359.","journal-title":"Sci Rep"},{"key":"3599_CR15","doi-asserted-by":"crossref","unstructured":"Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochimica et biophysica acta (BBA)-General subjects. 1986;883(2):173\u20137.","DOI":"10.1016\/0304-4165(86)90306-5"},{"issue":"11","key":"3599_CR16","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1002\/art.39293","volume":"67","author":"MM Caron","year":"2015","unstructured":"Caron MM, Emans PJ, van der Surtel DA, van Rhijn LW, Welting TJ. BAPX-1\/NKX\u20103.2 acts as a chondrocyte hypertrophy molecular switch in osteoarthritis. Arthritis Rheumatol. 2015;67(11):2944\u201356.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"3599_CR17","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.3390\/molecules25102314","volume":"25","author":"BJ Evans","year":"2020","unstructured":"Evans BJ, King AT, Katsifis A, Matesic L, Jamie JF. Methods to enhance the metabolic stability of peptide-based PET radiopharmaceuticals. Molecules. 2020;25(10):2314.","journal-title":"Molecules"},{"key":"3599_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0076-6879(09)62001-2","volume":"462","author":"LM Szewczuk","year":"2009","unstructured":"Szewczuk LM, Tarrant MK, Cole PA. Protein phosphorylation by semisynthesis: from paper to practice. Methods Enzymol. 2009;462:1\u201324.","journal-title":"Methods Enzymol"},{"issue":"5","key":"3599_CR19","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1021\/cr500399p","volume":"115","author":"O Boutureira","year":"2015","unstructured":"Boutureira O, Bernardes GJ. Advances in chemical protein modification. Chem Rev. 2015;115(5):2174\u201395.","journal-title":"Chem Rev"},{"key":"3599_CR20","doi-asserted-by":"publisher","first-page":"111826","DOI":"10.1016\/j.ejmech.2019.111826","volume":"186","author":"H Mei","year":"2020","unstructured":"Mei H, Han J, Klika KD, Izawa K, Sato T, Meanwell NA, et al. Applications of fluorine-containing amino acids for drug design. Eur J Med Chem. 2020;186:111826.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"3599_CR21","first-page":"17","volume":"9","author":"M Kamel","year":"1991","unstructured":"Kamel M, Hanafi M, Bassiouni M. Inhibition of elastase enzyme release from human polymorphonuclear leukocytes by N-acetyl-galactosamine and N-acetyl-glucosamine. Clin Exp Rheumatol. 1991;9(1):17\u201321.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"3599_CR22","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1039\/D1MD00098E","volume":"12","author":"QN Vu","year":"2021","unstructured":"Vu QN, Young R, Sudhakar HK, Gao T, Huang T, Tan YS, et al. Cyclisation strategies for stabilising peptides with irregular conformations. RSC Med Chem. 2021;12(6):887\u2013901.","journal-title":"RSC Med Chem"},{"key":"3599_CR23","unstructured":"Method for. selecting a candidate drug compound2004 10 September 2004."},{"issue":"1","key":"3599_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13059-023-02973-2","volume":"24","author":"Y Nevers","year":"2023","unstructured":"Nevers Y, Glover NM, Dessimoz C, Lecompte O. Protein length distribution is remarkably uniform across the tree of life. Genome Biol. 2023;24(1):135.","journal-title":"Genome Biol"},{"issue":"1","key":"3599_CR25","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1038\/s41467-023-39909-0","volume":"14","author":"M Cagiada","year":"2023","unstructured":"Cagiada M, Bottaro S, Lindemose S, Schenstr\u00f8m SM, Stein A, Hartmann-Petersen R, et al. Discovering functionally important sites in proteins. Nat Commun. 2023;14(1):4175.","journal-title":"Nat Commun"},{"issue":"1","key":"3599_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s42004-024-01147-w","volume":"7","author":"M Kobayashi","year":"2024","unstructured":"Kobayashi M, Onozawa N, Matsuda K, Wakimoto T. Chemoenzymatic tandem cyclization for the facile synthesis of bicyclic peptides. Commun Chem. 2024;7(1):67.","journal-title":"Commun Chem"},{"issue":"6","key":"3599_CR27","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.joca.2022.11.007","volume":"31","author":"G n den Akker","year":"2023","unstructured":"Van den Akker G, Steijns J, Stassen R, Wasilewski G, Peeters L, Wijnands K, et al. Development of a cyclic-inverso ahsg\/fetuin A-based peptide for Inhibition of calcification in osteoarthritis. Osteoarthr Cartil. 2023;31(6):727\u201340.","journal-title":"Osteoarthr Cartil"},{"issue":"18","key":"3599_CR28","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1039\/D1OB00411E","volume":"19","author":"HC Hayes","year":"2021","unstructured":"Hayes HC, Luk LY, Tsai Y-H. Approaches for peptide and protein cyclisation. Org Biomol Chem. 2021;19(18):3983\u20134001.","journal-title":"Org Biomol Chem"},{"issue":"7","key":"3599_CR29","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3390\/ph16070996","volume":"16","author":"L Costa","year":"2023","unstructured":"Costa L, Sousa E, Fernandes C. Cyclic peptides in pipeline: what future for these great molecules? Pharmaceuticals. 2023;16(7):996.","journal-title":"Pharmaceuticals"},{"issue":"5","key":"3599_CR30","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41589-023-01496-y","volume":"20","author":"ML Merz","year":"2024","unstructured":"Merz ML, Habeshian S, Li B, David J-AG, Nielsen AL, Ji X, et al. De Novo development of small Cyclic peptides that are orally bioavailable. Nat Chem Biol. 2024;20(5):624\u201333.","journal-title":"Nat Chem Biol"},{"key":"3599_CR31","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2478\/ebtj-2023-0013","volume":"7","author":"M Besharati","year":"2023","unstructured":"Besharati M, Lackner M. Bioactive peptides: A review. EuroBiotech J. 2023;7:176\u201388.","journal-title":"EuroBiotech J"},{"issue":"51","key":"3599_CR32","doi-asserted-by":"publisher","first-page":"16144","DOI":"10.1021\/jacs.5b10595","volume":"137","author":"AJ Krauson","year":"2015","unstructured":"Krauson AJ, Hall OM, Fuselier T, Starr CG, Kauffman WB, Wimley WC. Conformational fine-tuning of pore-forming peptide potency and selectivity. J Am Chem Soc. 2015;137(51):16144\u201352.","journal-title":"J Am Chem Soc"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03599-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03599-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03599-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T07:31:07Z","timestamp":1757316667000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03599-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3599"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03599-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6411244\/v1","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics and consent to participate\n                      .","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Medical ethical permission was received from the Maastricht University Medical Center Medical Ethical Committee (approval number 2017\u2009\u2212\u20090183).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"MC and TW are listed as the inventors on filed patents: WO2017178251 and WO2017178253. TW, PE, and LR have shares in Chondropeptix BV.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}